New pill xanamem aims to slow Alzheimer's decline
NCT ID NCT06125951
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily 10 mg pill called Xanamem can safely slow memory and function loss in people with mild or moderate Alzheimer's dementia. About 247 participants will receive either Xanamem or a placebo for 36 weeks, with an option to continue the drug for up to 108 weeks. The main goal is to see if the drug improves scores on a standard dementia rating scale.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Xanamem (a drug taken as a daily pill)
What this could lead to
If successful, Xanamem could become a new daily treatment to slow cognitive and functional decline in early Alzheimer's disease.
What could go wrong
This is a mid-stage trial with only 247 participants, so results may not confirm benefit. The drug is still experimental, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ACW Investigative Site 101
Ivanhoe, Victoria, Australia
-
ACW Investigative Site 102
Kogarah, New South Wales, Australia
-
ACW Investigative Site 103
Erina, New South Wales, Australia
-
ACW Investigative Site 104
Nedlands, Western Australia, Australia
-
ACW Investigative Site 105
Chermside, Queensland, Australia
-
ACW Investigative Site 106
Darlinghurst, New South Wales, Australia
-
ACW Investigative Site 107
Macquarie Park, New South Wales, Australia
-
ACW Investigative Site 108
Malvern, Victoria, Australia
-
ACW Investigative Site 109
West Perth, Western Australia, Australia
-
ACW Investigative Site 110
Woodville South, South Australia, Australia
-
ACW Investigative Site 111
Newcastle, New South Wales, Australia
-
ACW Investigative Site 112
Parkville, Victoria, Australia
-
ACW Investigative Site 113
Birtinya, Queensland, Australia
-
ACW Investigative Site 114
Bedford Park, South Australia, Australia
-
ACW Investigative Site 115
Carlton, Victoria, Australia
-
ACW Investigative Site 203
Delray Beach, Florida, 33445, United States
-
ACW Investigative Site 206
Toms River, New Jersey, 08755, United States
-
ACW Investigative Site 207
Decatur, Georgia, 30030, United States
-
ACW Investigative Site 208
Englewood, Colorado, 80113, United States
-
ACW Investigative Site 209
Sherman Oaks, California, 91403, United States
-
ACW Investigative Site 210
Dayton, Ohio, 45459, United States
-
ACW Investigative Site 211
Denver, Colorado, 80218, United States
-
ACW Investigative Site 212
Portland, Oregon, 97225, United States
-
ACW Investigative Site 213
Orange, California, 92866, United States
-
ACW Investigative Site 214
Albany, New York, 12208, United States
-
ACW Investigative Site 215
Bellevue, Washington, 98007, United States
-
ACW Investigative Site 216
East Providence, Rhode Island, 02914, United States
-
ACW Investigative Site 217
Independence, Ohio, 44131, United States
-
ACW Investigative Site 218
Carlsbad, California, 92011, United States
-
ACW Investigative Site 219
Staten Island, New York, 10314, United States
-
ACW Investigative Site 220
Austin, Texas, 78757, United States
-
ACW Investigative site 201
Miami, Florida, 33176, United States
-
ACW Investigative site 202
New Port Richey, Florida, 34652, United States
-
ACW Investigative site 204
Orlando, Florida, 32803, United States
-
ACW Investigative site 205
The Villages, Florida, 32162, United States